Showing results (71-80 of 151) with videos related to

Sort By:
Pageof 16
RMD Open|July 21, 2023
Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis (AAV): part 1-treatment of granulomatosis with polyangiitis and microscopic polyangiitisJan Henrik Schirmer, Beatriz Sanchez-Alamo, Bernhard Hellmich, et al.
Rheumatology (Oxford, England)|January 27, 2021
New insights into the epidemiology of ANCA-associated vasculitides in Germany: results from a claims data studyBernhard Hellmich, Peter Lamprecht, Philip Spearpoint, et al.
RMD Open|June 22, 2023
Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis (AAV): Part 2 - Treatment of eosinophilic granulomatosis with polyangiitis and diagnosis and general management of AAVBeatriz Sanchez-Alamo, Jan Henrik Schirmer, Bernhard Hellmich, et al.
Rhinology|September 13, 2015
Manifestation of eosinophilic granulomatosis with polyangiitis in head and neckHannes Petersen, Paul Götz, Marcus Both, et al.
Rheumatology (Oxford, England)|January 8, 2013
Orbital masses in granulomatosis with polyangiitis are associated with a refractory course and a high burden of local damageJulia U Holle, Christopher Voigt, Marcus Both, et al.
Pharmacogenomics|February 20, 2016
Cyclophosphamide treatment-induced leukopenia rates in ANCA-associated vasculitis are influenced by variant CYP450 2C9 genotypesJan Henrik Schirmer, Jan Phillip Bremer, Frank Moosig, et al.
The Journal of Rheumatology|September 22, 2023
Cluster Analysis to Explore Clinical Subphenotypes of Eosinophilic Granulomatosis With PolyangiitisEmma Rubenstein, Carla Maldini, Augusto Vaglio, et al.
Allergy|January 23, 2026
Targeting Immunologic Pathways in Eosinophilic Granulomatosis With Polyangiitis: Translating Emerging Evidence Into Clinical PracticeHarold Wilson-Morkeh, Lior Seluk, Philipp Bosch, et al.
The American Journal of Pathology|May 10, 2002
Peripheral blood and granuloma CD4(+)CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosisAndras Komocsi, Peter Lamprecht, Elena Csernok, et al.
Nature Reviews. Rheumatology|May 20, 2026
Treatment strategies in giant cell arteritis and polymyalgia rheumatica: beyond glucocorticoidsFrancesco Muratore, Kenneth J Warrington, Christian Dejaco, et al.
Pageof 16